PLASMA ABNORMAL PROTHROMBIN LEVELS IN PATIENTS WITH SMALL HEPATOCELLULAR-CARCINOMA

Authors:
  • KOK OHNISHI
    K OHNISHI
  • FNF NOMURA
    F NOMURA
  • SIS IIDA
    S IIDA

  • 1 December 1988
    • journal article
    • research article
    • Vol. 83  (12) , 1386-1389
    • PMID:2461655
Abstract
The diagnostic value of plasma abnormal prothrombin (PIVKA-II) measurements in detecting relatively small hepatocellular carcinomas (HCC), less than 5 cm in diameter, was compared with that of serum .alpha.-fetoprotein (AFP) determinations. Among 18 patients with relatively small hepatocellular carcinoma (HCC), abnormal PIVKA-II values were found in only three (16.6%). Highly elevated serum AFP levels (> 200 ng/ml) relatively specific for HCC were seen also in three patients. However, nonspecific elevation of PIVKA-II in patients with liver cirrhosis not accompanied by HCC was much less than that of AFP. Although complementary, both tests appear to be of limited value in early detection of HCC, indicating that searches for other markers are necessary, to allow early detection of small HCC.

This publication has 1 reference indexed in Scilit: